News

Supported by Paddywagon bus tours, and with sponsorship from FORSA and O’Neills, the Palestinian touring party will continue ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...